scholarly journals Long-Term Cost-Effectiveness of Adult Spinal Deformity Surgery

2015 ◽  
Vol 5 (1_suppl) ◽  
pp. s-0035-1554556-s-0035-1554556
Author(s):  
Ian McCarthy ◽  
Chessie Robinson ◽  
Richard Hostin ◽  
Michael O'Brien ◽  
Christopher Ames ◽  
...  
2014 ◽  
Vol 14 (11) ◽  
pp. S128-S129
Author(s):  
Ian McCarthy ◽  
Chessie Robinson ◽  
Michael F. O'Brien ◽  
Munish C. Gupta ◽  
Christopher P. Ames ◽  
...  

Spine ◽  
2018 ◽  
Vol 43 (19) ◽  
pp. 1340-1346 ◽  
Author(s):  
Micheal Raad ◽  
Amit Jain ◽  
Brian J. Neuman ◽  
Hamid Hassanzadeh ◽  
Munish C. Gupta ◽  
...  

2020 ◽  
pp. 219256822096409
Author(s):  
Anthony M. Alvarado ◽  
Bryan A. Schatmeyer ◽  
Paul M. Arnold

Study Design: Review article. Objective: A review of the literature evaluating the cost-effectiveness of undergoing adult spinal deformity surgery and potential avenues for reducing costs. Methods: A review of the current literature and synthesis of data to provide an update on the cost effectiveness of undergoing adult spinal deformity surgery. Results: Compared with nonoperative management, operative management for adult spinal deformity is associated with improved patient-reported outcomes and quality of life; however, it is associated with significant financial and resource use. Conclusion: Operative management for adult spinal deformity has been shown to be effective but is associated with significant cost and resource utilization. The optimal operative treatment is highly dependent on the patients’ symptomatology and is surgeon dependent. Maximizing preoperative surgical health and minimizing postoperative complications are key measures in reducing the cost and resource utilization of adult spinal deformity surgery. Future studies are needed to evaluate how to optimize the cost-effectiveness.


2020 ◽  
Vol 33 (4) ◽  
pp. 490-495
Author(s):  
Mark Ren ◽  
Barry R. Bryant ◽  
Andrew B. Harris ◽  
Khaled M. Kebaish ◽  
Lee H. Riley ◽  
...  

OBJECTIVEThe objectives of the study were to determine, among patients with adult spinal deformity (ASD), the following: 1) how preoperative opioid use, dose, and duration of use are associated with long-term opioid use and dose; 2) how preoperative opioid use is associated with rates of postoperative use from 6 weeks to 2 years; and 3) how postoperative opioid use at 6 months and 1 year is associated with use at 2 years.METHODSUsing a single-center, longitudinally maintained registry, the authors identified 87 patients who underwent ASD surgery from 2013 to 2017. Fifty-nine patients reported preoperative opioid use (37 high-dose [≥ 90 morphine milligram equivalents daily] and 22 low-dose use). The duration of preoperative use was long-term (≥ 6 months) for 44 patients and short-term for 15. The authors evaluated postoperative opioid use at 6 weeks, 3 months, 6 months, 1 year, and 2 years after surgery. Multivariate logistic regression was used to determine associations of preoperative opioid use, dose, and duration with use at each time point (alpha = 0.05).RESULTSThe following preoperative factors were associated with opioid use 2 years postoperatively: any opioid use (adjusted odds ratio [aOR] 14, 95% CI 2.5–82), high-dose use (aOR 7.3, 95% CI 1.1–48), and long-term use (aOR 17, 95% CI 2.2–123). All patients who reported high-dose opioid use at the 2-year follow-up examination had also reported preoperative opioid use. Preoperative high-dose use (aOR 247, 95% CI 5.8–10,546) but not long-term use (aOR 4.0, 95% CI 0.18–91) was associated with high-dose use at the 2-year follow-up visit. Compared with patients who reported no preoperative use, those who reported preoperative opioid use had higher rates of use at each postoperative time point (from 94% vs 62% at 6 weeks to 54% vs 7.1% at 2 years) (all p < 0.001). Opioid use at 2 years was independently associated with use at 1 year (aOR 33, 95% CI 6.8–261) but not at 6 months (aOR 4.3, 95% CI 0.95–24).CONCLUSIONSPatients’ preoperative opioid use, dose, and duration of use are associated with long-term use after ASD surgery, and a high preoperative dose is also associated with high-dose opioid use at the 2-year follow-up visit. Patients using opioids 1 year after ASD surgery may be at risk for long-term use.


2019 ◽  
Vol 122 ◽  
pp. 171-175
Author(s):  
Gurpreet S. Gandhoke ◽  
Kenneth J. Smith ◽  
Yash K. Pandya ◽  
Nima Alan ◽  
Adam S. Kanter ◽  
...  

2015 ◽  
Vol 5 (1_suppl) ◽  
pp. s-0035-1554557-s-0035-1554557
Author(s):  
Chessie Robinson ◽  
Richard Hostin ◽  
Ian McCarthy ◽  
Michael O'Brien ◽  
Munish Gupta ◽  
...  

2019 ◽  
Vol 19 (9) ◽  
pp. S125
Author(s):  
Mark Ren ◽  
Barry R. Bryant ◽  
Andrew B. Harris ◽  
Richard L. Skolasky ◽  
Khaled M. Kebaish ◽  
...  

2013 ◽  
Vol 13 (9) ◽  
pp. S96-S97
Author(s):  
Ian McCarthy ◽  
Michael O’Brien ◽  
Christopher P. Ames ◽  
Thomas J. Errico ◽  
Han Jo Kim ◽  
...  

2014 ◽  
Vol 14 (11) ◽  
pp. S129
Author(s):  
Chessie Robinson ◽  
Ian McCarthy ◽  
Michael F. O'Brien ◽  
Munish C. Gupta ◽  
Christopher P. Ames ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document